Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxa5
|
ENSMUSG00000038253.6 | homeobox A5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_52202371_52204739 | Hoxa5 | 1032 | 0.200120 | -0.17 | 2.1e-01 | Click! |
chr6_52204772_52205209 | Hoxa5 | 403 | 0.555114 | -0.03 | 8.2e-01 | Click! |
chr6_52205266_52206926 | Hoxa5 | 1509 | 0.125778 | 0.01 | 9.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_5724213_5725550 | 8.82 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chr5_135806693_135807939 | 8.48 |
Srrm3 |
serine/arginine repetitive matrix 3 |
419 |
0.73 |
chrX_84076569_84077653 | 8.35 |
Dmd |
dystrophin, muscular dystrophy |
462 |
0.87 |
chr12_71048832_71049275 | 8.17 |
Arid4a |
AT rich interactive domain 4A (RBP1-like) |
712 |
0.65 |
chr12_29529828_29531185 | 8.12 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr2_97468266_97469202 | 7.93 |
Lrrc4c |
leucine rich repeat containing 4C |
645 |
0.83 |
chr2_6881874_6882908 | 7.13 |
Gm13389 |
predicted gene 13389 |
1879 |
0.3 |
chr6_55678280_55679200 | 6.84 |
Neurod6 |
neurogenic differentiation 6 |
2523 |
0.32 |
chr4_13747506_13748460 | 6.83 |
Runx1t1 |
RUNX1 translocation partner 1 |
3314 |
0.37 |
chr16_43505394_43505961 | 6.75 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1980 |
0.41 |
chr16_77594640_77595970 | 6.65 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
403 |
0.71 |
chrX_23283125_23283785 | 6.64 |
Klhl13 |
kelch-like 13 |
1374 |
0.57 |
chr8_14382368_14383445 | 6.52 |
Dlgap2 |
DLG associated protein 2 |
910 |
0.66 |
chr9_113813101_113813610 | 6.22 |
Clasp2 |
CLIP associating protein 2 |
755 |
0.71 |
chr2_70564530_70567543 | 6.20 |
Gad1 |
glutamate decarboxylase 1 |
341 |
0.83 |
chr18_25749825_25750329 | 6.17 |
Celf4 |
CUGBP, Elav-like family member 4 |
2615 |
0.33 |
chr1_32174771_32175297 | 6.12 |
Khdrbs2 |
KH domain containing, RNA binding, signal transduction associated 2 |
2147 |
0.41 |
chr2_7395418_7396363 | 6.05 |
Celf2 |
CUGBP, Elav-like family member 2 |
3 |
0.99 |
chr10_90578974_90579573 | 6.04 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
2281 |
0.42 |
chr8_54956010_54956394 | 6.04 |
Gpm6a |
glycoprotein m6a |
1359 |
0.38 |
chr18_59062200_59063436 | 5.99 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
307 |
0.94 |
chr3_101379658_101381123 | 5.97 |
Igsf3 |
immunoglobulin superfamily, member 3 |
2052 |
0.26 |
chr9_75682602_75682827 | 5.89 |
Scg3 |
secretogranin III |
873 |
0.53 |
chr6_32584464_32585789 | 5.88 |
Plxna4 |
plexin A4 |
3066 |
0.3 |
chr8_123412815_123413352 | 5.88 |
Tubb3 |
tubulin, beta 3 class III |
1493 |
0.18 |
chr10_90577565_90578158 | 5.84 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
869 |
0.72 |
chr8_109250884_109251908 | 5.83 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1530 |
0.52 |
chr1_157243489_157244692 | 5.83 |
Rasal2 |
RAS protein activator like 2 |
400 |
0.88 |
chr18_25751839_25752425 | 5.81 |
Celf4 |
CUGBP, Elav-like family member 4 |
560 |
0.81 |
chr12_41483283_41485192 | 5.73 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
2194 |
0.36 |
chr2_32428080_32429746 | 5.73 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
1839 |
0.19 |
chr3_68573207_68574269 | 5.70 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chr6_103513736_103514218 | 5.70 |
Chl1 |
cell adhesion molecule L1-like |
2647 |
0.25 |
chr6_55680133_55680881 | 5.70 |
Neurod6 |
neurogenic differentiation 6 |
756 |
0.69 |
chr8_54954519_54955779 | 5.67 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr6_96113911_96115198 | 5.66 |
Tafa1 |
TAFA chemokine like family member 1 |
95 |
0.98 |
chr10_64084748_64085397 | 5.63 |
Lrrtm3 |
leucine rich repeat transmembrane neuronal 3 |
5175 |
0.34 |
chr15_68930024_68930460 | 5.63 |
Khdrbs3 |
KH domain containing, RNA binding, signal transduction associated 3 |
174 |
0.96 |
chr6_83185720_83187846 | 5.62 |
Dctn1 |
dynactin 1 |
837 |
0.39 |
chr13_14520339_14520490 | 5.57 |
Gm30893 |
predicted gene, 30893 |
1072 |
0.37 |
chr11_34315414_34316667 | 5.53 |
Insyn2b |
inhibitory synaptic factor family member 2B |
1218 |
0.45 |
chr2_65620767_65621991 | 5.50 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
568 |
0.82 |
chr6_21217917_21219303 | 5.49 |
Kcnd2 |
potassium voltage-gated channel, Shal-related family, member 2 |
3107 |
0.33 |
chr7_92234907_92236280 | 5.41 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr3_156563859_156564302 | 5.40 |
Negr1 |
neuronal growth regulator 1 |
1930 |
0.33 |
chr8_41054160_41054452 | 5.38 |
Mtus1 |
mitochondrial tumor suppressor 1 |
477 |
0.69 |
chr13_83715222_83716973 | 5.37 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5284 |
0.15 |
chr16_69469508_69470143 | 5.28 |
4930428D20Rik |
RIKEN cDNA 4930428D20 gene |
330556 |
0.01 |
chr16_77645925_77646470 | 5.24 |
Mir125b-2 |
microRNA 125b-2 |
76 |
0.58 |
chr6_110649216_110650077 | 5.19 |
Gm20387 |
predicted gene 20387 |
3730 |
0.27 |
chr13_36732776_36733340 | 5.15 |
Nrn1 |
neuritin 1 |
1312 |
0.4 |
chr5_103209022_103210413 | 5.12 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr8_67817715_67818694 | 5.12 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
29 |
0.99 |
chr12_31710202_31710828 | 5.12 |
Gpr22 |
G protein-coupled receptor 22 |
3411 |
0.2 |
chr18_35212708_35213458 | 5.09 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
1847 |
0.28 |
chr4_78209143_78209724 | 5.08 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
2306 |
0.29 |
chr1_115684558_115685809 | 5.07 |
Cntnap5a |
contactin associated protein-like 5A |
427 |
0.58 |
chr3_80799469_80799764 | 5.07 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
2963 |
0.34 |
chr2_52557337_52558561 | 5.05 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
611 |
0.74 |
chr2_65565600_65566271 | 5.04 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
1557 |
0.45 |
chr8_62952898_62953049 | 5.03 |
Spock3 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
1048 |
0.57 |
chr8_109248831_109249717 | 5.01 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
592 |
0.83 |
chr1_143643975_143644626 | 5.00 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
1775 |
0.33 |
chr16_16558986_16560577 | 4.99 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
209 |
0.94 |
chr10_96622833_96623426 | 4.96 |
Btg1 |
BTG anti-proliferation factor 1 |
5575 |
0.22 |
chr7_60939270_60939914 | 4.96 |
Gm44644 |
predicted gene 44644 |
16682 |
0.22 |
chr11_94045498_94046076 | 4.95 |
Spag9 |
sperm associated antigen 9 |
1422 |
0.4 |
chr1_3669608_3669968 | 4.94 |
Xkr4 |
X-linked Kx blood group related 4 |
1710 |
0.33 |
chr12_46816152_46816702 | 4.93 |
Nova1 |
NOVA alternative splicing regulator 1 |
533 |
0.8 |
chr8_33746530_33746945 | 4.88 |
Smim18 |
small integral membrane protein 18 |
1033 |
0.44 |
chr13_44946654_44947258 | 4.88 |
Dtnbp1 |
dystrobrevin binding protein 1 |
188 |
0.96 |
chr1_25228097_25229399 | 4.88 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
78 |
0.96 |
chr1_64116857_64117480 | 4.88 |
Klf7 |
Kruppel-like factor 7 (ubiquitous) |
4314 |
0.23 |
chr4_102761968_102762422 | 4.86 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
1670 |
0.44 |
chrX_166348094_166348432 | 4.86 |
Gpm6b |
glycoprotein m6b |
3421 |
0.29 |
chr12_108605770_108606876 | 4.80 |
Evl |
Ena-vasodilator stimulated phosphoprotein |
557 |
0.74 |
chr5_112574293_112574972 | 4.80 |
Sez6l |
seizure related 6 homolog like |
2236 |
0.24 |
chr2_146745280_146745983 | 4.78 |
Gm14111 |
predicted gene 14111 |
10074 |
0.27 |
chr3_17789318_17789657 | 4.77 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
434 |
0.83 |
chr4_109155589_109157355 | 4.76 |
Osbpl9 |
oxysterol binding protein-like 9 |
138 |
0.97 |
chr12_86681553_86682494 | 4.76 |
Vash1 |
vasohibin 1 |
3323 |
0.18 |
chr1_177446374_177448525 | 4.75 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
1628 |
0.31 |
chr15_96283141_96283622 | 4.74 |
2610037D02Rik |
RIKEN cDNA 2610037D02 gene |
227 |
0.93 |
chr2_181768465_181769553 | 4.74 |
Myt1 |
myelin transcription factor 1 |
1497 |
0.33 |
chr9_113811975_113812935 | 4.74 |
Clasp2 |
CLIP associating protein 2 |
131 |
0.97 |
chr6_136167149_136168437 | 4.70 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
4096 |
0.25 |
chr3_134330789_134331989 | 4.68 |
Gm43558 |
predicted gene 43558 |
25903 |
0.15 |
chr2_77701567_77703605 | 4.61 |
Zfp385b |
zinc finger protein 385B |
686 |
0.8 |
chr5_98182267_98183697 | 4.61 |
Prdm8 |
PR domain containing 8 |
2004 |
0.26 |
chr6_105678414_105679444 | 4.57 |
Cntn4 |
contactin 4 |
1154 |
0.43 |
chr13_44946033_44946635 | 4.56 |
Dtnbp1 |
dystrobrevin binding protein 1 |
810 |
0.7 |
chr10_49785211_49786117 | 4.54 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
2255 |
0.25 |
chr8_109245493_109246323 | 4.53 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
3958 |
0.33 |
chr1_9297044_9297295 | 4.53 |
Sntg1 |
syntrophin, gamma 1 |
1067 |
0.5 |
chr9_110051810_110053856 | 4.52 |
Map4 |
microtubule-associated protein 4 |
781 |
0.54 |
chr2_65668738_65669312 | 4.52 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
260 |
0.95 |
chr19_38263947_38265363 | 4.46 |
Lgi1 |
leucine-rich repeat LGI family, member 1 |
5 |
0.97 |
chr5_65130636_65132102 | 4.45 |
Klhl5 |
kelch-like 5 |
34 |
0.97 |
chr13_83724722_83725570 | 4.41 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2960 |
0.17 |
chr1_92849002_92850443 | 4.41 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr3_89243498_89245184 | 4.39 |
Trim46 |
tripartite motif-containing 46 |
672 |
0.36 |
chr5_5264770_5266186 | 4.38 |
Cdk14 |
cyclin-dependent kinase 14 |
169 |
0.96 |
chr3_26151491_26152156 | 4.38 |
Nlgn1 |
neuroligin 1 |
1484 |
0.58 |
chr4_9270530_9270692 | 4.38 |
Clvs1 |
clavesin 1 |
844 |
0.67 |
chr13_28881136_28881895 | 4.37 |
2610307P16Rik |
RIKEN cDNA 2610307P16 gene |
1941 |
0.32 |
chr10_92160735_92161461 | 4.36 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
1663 |
0.4 |
chr15_98952050_98952507 | 4.36 |
Gm49450 |
predicted gene, 49450 |
1273 |
0.2 |
chr16_43507761_43509014 | 4.35 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
124 |
0.97 |
chr10_109008310_109009456 | 4.31 |
Syt1 |
synaptotagmin I |
217 |
0.96 |
chr5_106200812_106201588 | 4.30 |
Gm5987 |
predicted gene 5987 |
14451 |
0.21 |
chr4_25797578_25797990 | 4.29 |
Fut9 |
fucosyltransferase 9 |
2071 |
0.32 |
chr16_13357876_13359918 | 4.28 |
Mrtfb |
myocardin related transcription factor B |
476 |
0.83 |
chr13_20473087_20474265 | 4.26 |
Gm32036 |
predicted gene, 32036 |
186 |
0.89 |
chr16_77597699_77598173 | 4.25 |
Mir99a |
microRNA 99a |
1000 |
0.31 |
chr18_40259056_40260097 | 4.25 |
Kctd16 |
potassium channel tetramerisation domain containing 16 |
773 |
0.5 |
chrX_152642489_152643012 | 4.24 |
Shroom2 |
shroom family member 2 |
1174 |
0.54 |
chr3_67892003_67892637 | 4.23 |
Iqschfp |
Iqcj and Schip1 fusion protein |
88 |
0.51 |
chr18_35211196_35211574 | 4.23 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
3545 |
0.21 |
chr12_86880278_86881016 | 4.23 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
4151 |
0.21 |
chr12_107951990_107953098 | 4.22 |
Bcl11b |
B cell leukemia/lymphoma 11B |
50870 |
0.16 |
chr1_177448882_177449429 | 4.22 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
3334 |
0.19 |
chr12_52700044_52701597 | 4.20 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
1437 |
0.46 |
chr5_84413029_84413589 | 4.19 |
Epha5 |
Eph receptor A5 |
3497 |
0.31 |
chr3_84953332_84953942 | 4.19 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
1491 |
0.53 |
chr6_86031081_86032013 | 4.18 |
Add2 |
adducin 2 (beta) |
2800 |
0.16 |
chr15_77150114_77150989 | 4.18 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
3005 |
0.19 |
chr1_143644977_143645827 | 4.16 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
2877 |
0.24 |
chr17_81667571_81668254 | 4.14 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
2275 |
0.44 |
chr6_49824417_49824871 | 4.13 |
Npy |
neuropeptide Y |
1934 |
0.4 |
chr8_34889322_34889790 | 4.12 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
595 |
0.79 |
chr4_102760289_102761654 | 4.10 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
446 |
0.87 |
chrX_166346283_166346827 | 4.09 |
Gpm6b |
glycoprotein m6b |
1713 |
0.43 |
chr7_126950022_126951260 | 4.09 |
Sez6l2 |
seizure related 6 homolog like 2 |
57 |
0.89 |
chr10_34299043_34301066 | 4.09 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr19_47018258_47018719 | 4.07 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
3335 |
0.15 |
chr14_75962509_75963193 | 4.06 |
Kctd4 |
potassium channel tetramerisation domain containing 4 |
7842 |
0.18 |
chr10_90830503_90831025 | 4.00 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
921 |
0.56 |
chr6_13832197_13832750 | 4.00 |
Gpr85 |
G protein-coupled receptor 85 |
4768 |
0.23 |
chr16_77646908_77647363 | 3.99 |
C130023A14Rik |
RIKEN cDNA C130023A14 gene |
795 |
0.35 |
chr11_104233637_104234521 | 3.99 |
Mapt |
microtubule-associated protein tau |
2495 |
0.22 |
chr1_25827305_25827886 | 3.99 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
835 |
0.43 |
chr17_78202551_78203154 | 3.99 |
Crim1 |
cysteine rich transmembrane BMP regulator 1 (chordin like) |
1787 |
0.27 |
chr1_23765216_23765741 | 3.97 |
B3gat2 |
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) |
3467 |
0.34 |
chr17_51760240_51761547 | 3.96 |
C230085N15Rik |
RIKEN cDNA C230085N15 gene |
728 |
0.54 |
chr1_50928853_50929386 | 3.95 |
Tmeff2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
1600 |
0.44 |
chr8_94266327_94267391 | 3.95 |
Nup93 |
nucleoporin 93 |
12 |
0.96 |
chr18_31316134_31317386 | 3.95 |
Rit2 |
Ras-like without CAAX 2 |
351 |
0.9 |
chr1_81079064_81079824 | 3.95 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
1861 |
0.49 |
chr19_6499251_6500132 | 3.94 |
Nrxn2 |
neurexin II |
1856 |
0.23 |
chr1_25824008_25825247 | 3.92 |
2900002M20Rik |
RIKEN cDNA 2900002M20 gene |
92 |
0.93 |
chr2_6881042_6881689 | 3.89 |
Gm13389 |
predicted gene 13389 |
2905 |
0.24 |
chr6_54041337_54041980 | 3.89 |
Chn2 |
chimerin 2 |
1572 |
0.42 |
chr14_93883900_93884713 | 3.89 |
Pcdh9 |
protocadherin 9 |
1442 |
0.55 |
chr13_28416755_28419194 | 3.88 |
Gm40841 |
predicted gene, 40841 |
1889 |
0.42 |
chr3_38892303_38893788 | 3.88 |
Fat4 |
FAT atypical cadherin 4 |
2103 |
0.36 |
chr4_82499658_82501360 | 3.87 |
Nfib |
nuclear factor I/B |
1193 |
0.5 |
chr8_35591141_35592463 | 3.86 |
Gm16793 |
predicted gene, 16793 |
2830 |
0.24 |
chr1_77503797_77505059 | 3.86 |
Mir6352 |
microRNA 6352 |
7660 |
0.19 |
chr10_49786487_49786915 | 3.86 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
2053 |
0.25 |
chr10_92164315_92164805 | 3.85 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
106 |
0.97 |
chr9_121403057_121404479 | 3.85 |
Trak1 |
trafficking protein, kinesin binding 1 |
290 |
0.91 |
chr1_132541040_132543287 | 3.84 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr9_41378412_41379411 | 3.83 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2350 |
0.27 |
chr1_143640264_143641520 | 3.83 |
B3galt2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
228 |
0.59 |
chr6_47244410_47244958 | 3.82 |
Cntnap2 |
contactin associated protein-like 2 |
231 |
0.96 |
chr5_107498769_107499247 | 3.82 |
Btbd8 |
BTB (POZ) domain containing 8 |
1229 |
0.33 |
chr14_64574784_64575443 | 3.82 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
12218 |
0.15 |
chr13_83717521_83718816 | 3.81 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3213 |
0.17 |
chr1_119419067_119420042 | 3.81 |
Inhbb |
inhibin beta-B |
2694 |
0.27 |
chr10_57788062_57788258 | 3.81 |
Fabp7 |
fatty acid binding protein 7, brain |
3237 |
0.22 |
chr15_85680534_85681451 | 3.81 |
Lncppara |
long noncoding RNA near Ppara |
22781 |
0.12 |
chr1_159523756_159524611 | 3.80 |
Tnr |
tenascin R |
342 |
0.91 |
chr15_78116860_78117881 | 3.79 |
A730060N03Rik |
RIKEN cDNA A730060N03 gene |
2336 |
0.22 |
chr6_28828230_28829085 | 3.78 |
Lrrc4 |
leucine rich repeat containing 4 |
1688 |
0.37 |
chr3_4796861_4798079 | 3.77 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
88 |
0.98 |
chr16_77235519_77235701 | 3.77 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
707 |
0.75 |
chr10_73821409_73822534 | 3.77 |
Pcdh15 |
protocadherin 15 |
28 |
0.99 |
chr19_8838893_8839483 | 3.77 |
Gng3 |
guanine nucleotide binding protein (G protein), gamma 3 |
6 |
0.61 |
chr1_22803060_22803872 | 3.75 |
Rims1 |
regulating synaptic membrane exocytosis 1 |
2258 |
0.42 |
chr15_18820164_18820708 | 3.75 |
Cdh10 |
cadherin 10 |
107 |
0.96 |
chr1_69790500_69791180 | 3.75 |
Gm37930 |
predicted gene, 37930 |
19972 |
0.21 |
chr14_93887180_93887734 | 3.74 |
Pcdh9 |
protocadherin 9 |
1233 |
0.6 |
chr1_70726785_70727115 | 3.73 |
Vwc2l |
von Willebrand factor C domain-containing protein 2-like |
1027 |
0.69 |
chr8_67973559_67974885 | 3.73 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
352 |
0.89 |
chr16_74407688_74408034 | 3.72 |
Robo2 |
roundabout guidance receptor 2 |
3051 |
0.35 |
chr12_61525659_61526870 | 3.71 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
2316 |
0.3 |
chr2_70561988_70564432 | 3.70 |
Gad1os |
glutamate decarboxylase 1, opposite strand |
147 |
0.61 |
chr6_55679226_55679709 | 3.70 |
Neurod6 |
neurogenic differentiation 6 |
1796 |
0.39 |
chr12_72233267_72233815 | 3.69 |
Rtn1 |
reticulon 1 |
2198 |
0.35 |
chr4_110284419_110284817 | 3.68 |
Elavl4 |
ELAV like RNA binding protein 4 |
1998 |
0.47 |
chr2_62046631_62048214 | 3.68 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
777 |
0.76 |
chr12_119235620_119236481 | 3.66 |
Itgb8 |
integrin beta 8 |
2720 |
0.31 |
chr18_37217058_37218378 | 3.64 |
Gm10544 |
predicted gene 10544 |
39196 |
0.08 |
chrX_61116034_61117613 | 3.63 |
Cdr1os |
cerebellar degeneration related antigen 1, opposite strand |
425 |
0.47 |
chr9_91369028_91370469 | 3.63 |
Zic4 |
zinc finger protein of the cerebellum 4 |
250 |
0.86 |
chr2_65566312_65566743 | 3.62 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
965 |
0.63 |
chr3_146768414_146769205 | 3.62 |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
1452 |
0.4 |
chr4_9269280_9270516 | 3.61 |
Clvs1 |
clavesin 1 |
551 |
0.81 |
chr11_104234777_104235157 | 3.61 |
Mapt |
microtubule-associated protein tau |
3383 |
0.19 |
chr18_52770067_52770425 | 3.60 |
Sncaip |
synuclein, alpha interacting protein (synphilin) |
1514 |
0.47 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 20.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.6 | 4.6 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
4.2 | 12.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
4.0 | 12.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.9 | 11.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
3.5 | 10.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
3.5 | 10.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.4 | 24.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
3.4 | 13.7 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
3.2 | 9.7 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
3.1 | 9.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.9 | 8.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.9 | 31.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.9 | 11.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.8 | 8.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
2.7 | 21.9 | GO:0071625 | vocalization behavior(GO:0071625) |
2.7 | 8.0 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.7 | 15.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.6 | 7.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.6 | 2.6 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
2.5 | 12.6 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
2.5 | 2.5 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
2.3 | 7.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
2.2 | 8.9 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.2 | 4.4 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
2.2 | 13.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
2.1 | 6.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
2.1 | 12.8 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
2.1 | 6.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
2.1 | 8.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
2.1 | 2.1 | GO:0021828 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
2.0 | 6.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.9 | 1.9 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
1.8 | 16.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.8 | 3.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.8 | 5.4 | GO:1903365 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
1.7 | 10.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.7 | 8.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.7 | 1.7 | GO:1902474 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
1.6 | 4.9 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.6 | 6.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.6 | 14.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.6 | 6.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.5 | 4.6 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.5 | 33.5 | GO:0001964 | startle response(GO:0001964) |
1.5 | 3.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.5 | 8.9 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.5 | 7.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.5 | 1.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.4 | 4.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.4 | 24.2 | GO:0060074 | synapse maturation(GO:0060074) |
1.4 | 11.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.4 | 5.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.4 | 4.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.4 | 4.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.4 | 1.4 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.4 | 2.7 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.3 | 4.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.3 | 4.0 | GO:0060174 | limb bud formation(GO:0060174) |
1.3 | 1.3 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
1.3 | 9.1 | GO:0097264 | self proteolysis(GO:0097264) |
1.3 | 7.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.3 | 3.9 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
1.3 | 1.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
1.3 | 5.1 | GO:0030091 | protein repair(GO:0030091) |
1.2 | 10.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.2 | 8.5 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
1.2 | 6.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.2 | 7.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
1.2 | 3.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.2 | 3.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.2 | 3.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.2 | 4.6 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.2 | 2.3 | GO:0046959 | habituation(GO:0046959) |
1.1 | 4.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.1 | 3.4 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.1 | 5.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.1 | 3.4 | GO:0030070 | insulin processing(GO:0030070) |
1.1 | 3.4 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
1.1 | 4.5 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
1.1 | 3.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.1 | 2.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.1 | 1.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.1 | 2.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.1 | 4.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.1 | 7.5 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.0 | 3.1 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.0 | 1.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.0 | 3.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.0 | 4.0 | GO:0030035 | microspike assembly(GO:0030035) |
1.0 | 1.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.0 | 3.0 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.0 | 2.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.0 | 5.0 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.0 | 3.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.0 | 3.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.0 | 4.9 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.0 | 2.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.9 | 9.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.9 | 5.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.9 | 0.9 | GO:0060686 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.9 | 0.9 | GO:0060073 | micturition(GO:0060073) |
0.9 | 1.9 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.9 | 4.7 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.9 | 2.8 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.9 | 3.7 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.9 | 6.4 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.9 | 15.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.9 | 5.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.9 | 0.9 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.9 | 2.7 | GO:1904395 | positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.9 | 6.1 | GO:0008038 | neuron recognition(GO:0008038) |
0.9 | 5.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.9 | 4.3 | GO:0030432 | peristalsis(GO:0030432) |
0.9 | 4.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.9 | 1.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.9 | 7.7 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.8 | 2.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.8 | 0.8 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.8 | 4.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.8 | 0.8 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.8 | 0.8 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.8 | 0.8 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.8 | 0.8 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.8 | 65.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.8 | 3.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.8 | 34.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.8 | 4.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.8 | 3.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.8 | 0.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.8 | 2.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.8 | 0.8 | GO:0015808 | L-alanine transport(GO:0015808) |
0.8 | 3.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.8 | 2.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.8 | 6.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.8 | 1.6 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.8 | 2.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.8 | 0.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.8 | 0.8 | GO:0035482 | gastric motility(GO:0035482) |
0.8 | 6.0 | GO:0045176 | apical protein localization(GO:0045176) |
0.8 | 0.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.8 | 3.8 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.7 | 1.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.7 | 2.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 5.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.7 | 7.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.7 | 1.5 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.7 | 2.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.7 | 0.7 | GO:0097369 | sodium ion import(GO:0097369) |
0.7 | 8.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.7 | 3.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.7 | 2.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.7 | 1.4 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.7 | 14.3 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.7 | 2.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.7 | 6.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.7 | 0.7 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.7 | 11.3 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.7 | 1.4 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.7 | 3.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.7 | 0.7 | GO:0034776 | response to histamine(GO:0034776) |
0.7 | 2.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.7 | 0.7 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.7 | 8.8 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.7 | 2.7 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.7 | 4.7 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.7 | 2.0 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.7 | 2.6 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.7 | 1.3 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.6 | 4.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.6 | 3.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.6 | 6.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.6 | 4.5 | GO:1902287 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.6 | 1.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.6 | 0.6 | GO:0036493 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.6 | 2.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.6 | 1.9 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.6 | 3.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.6 | 5.6 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.6 | 1.9 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.6 | 0.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.6 | 1.8 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.6 | 12.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 1.8 | GO:0097503 | sialylation(GO:0097503) |
0.6 | 1.8 | GO:0086014 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.6 | 0.6 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.6 | 10.9 | GO:0007616 | long-term memory(GO:0007616) |
0.6 | 1.8 | GO:0045162 | neuronal ion channel clustering(GO:0045161) clustering of voltage-gated sodium channels(GO:0045162) |
0.6 | 4.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.6 | 2.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.6 | 1.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.6 | 1.8 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.6 | 4.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.6 | 1.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 1.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.6 | 0.6 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.6 | 2.9 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.6 | 2.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.6 | 0.6 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.6 | 5.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.6 | 1.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.6 | 1.7 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.6 | 2.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.6 | 0.6 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.6 | 0.6 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.6 | 1.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.6 | 2.3 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.6 | 0.6 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.6 | 0.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.6 | 1.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.6 | 1.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.6 | 2.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 | 0.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.6 | 3.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.6 | 1.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.5 | 3.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.5 | 2.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 4.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.5 | 5.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.5 | 1.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.5 | 3.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 1.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.5 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.5 | 1.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.5 | 3.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.5 | 3.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 1.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 2.1 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.5 | 8.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 1.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 1.5 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.5 | 1.5 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.5 | 3.6 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.5 | 1.0 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.5 | 3.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.5 | 6.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 3.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 1.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 1.5 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 1.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 3.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 2.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 1.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.5 | 0.5 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.5 | 3.0 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 1.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 3.0 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.5 | 0.5 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.5 | 3.4 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.5 | 2.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.5 | 1.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.5 | 1.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.5 | 42.7 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.5 | 4.3 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.5 | 1.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 0.5 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.5 | 8.1 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.5 | 1.9 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.5 | 28.5 | GO:0007612 | learning(GO:0007612) |
0.5 | 1.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.5 | 1.4 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.5 | 1.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.5 | 1.8 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 0.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.5 | 1.4 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.5 | 5.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.5 | 0.9 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.5 | 0.5 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.5 | 2.3 | GO:0060004 | reflex(GO:0060004) |
0.5 | 3.2 | GO:0015824 | proline transport(GO:0015824) |
0.4 | 2.2 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 2.6 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.4 | 0.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.4 | 5.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.4 | 2.2 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.4 | 1.3 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.4 | 2.2 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.4 | 0.4 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.4 | 10.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 1.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 1.3 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 1.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.4 | 0.4 | GO:0007632 | visual behavior(GO:0007632) |
0.4 | 1.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 1.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 1.2 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
0.4 | 1.7 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 1.2 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.4 | 0.8 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.4 | 40.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.4 | 0.8 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.4 | 0.8 | GO:0015819 | lysine transport(GO:0015819) |
0.4 | 2.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.4 | 1.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 0.8 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 3.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 1.9 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 0.4 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.4 | 1.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 2.7 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.4 | 0.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 1.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.4 | 3.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.4 | 1.9 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.4 | 1.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.4 | 1.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.4 | 1.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.4 | 1.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.4 | 0.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.4 | 1.5 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.4 | 2.2 | GO:0015846 | polyamine transport(GO:0015846) |
0.4 | 0.4 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.4 | 2.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.4 | 2.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.4 | 1.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.4 | 0.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 1.8 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.4 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.4 | 0.4 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.4 | 4.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 0.7 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 1.4 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.3 | 1.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 1.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 1.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.3 | 1.7 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.3 | 1.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 0.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.3 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 1.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 0.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 0.3 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.3 | 2.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 1.3 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 1.0 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.3 | 0.7 | GO:0042220 | response to cocaine(GO:0042220) |
0.3 | 3.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.3 | 1.0 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.3 | 2.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.3 | 1.0 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.3 | 0.7 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.3 | 1.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.3 | 2.0 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.3 | 0.7 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.3 | 0.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.3 | 0.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 0.6 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 1.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.3 | 1.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 1.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 1.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.3 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.3 | 3.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.3 | 0.3 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
0.3 | 0.3 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.3 | 2.5 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.3 | 0.3 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.3 | 0.3 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.3 | 0.6 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.3 | 0.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 0.6 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.3 | 2.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 3.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 1.5 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.3 | 0.9 | GO:0032202 | telomere assembly(GO:0032202) |
0.3 | 0.9 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 0.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 0.3 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.3 | 0.9 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.3 | 1.5 | GO:0072044 | collecting duct development(GO:0072044) |
0.3 | 1.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 0.9 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 4.4 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.3 | 1.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.3 | 1.2 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 0.3 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 0.3 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.3 | 0.6 | GO:0032328 | alanine transport(GO:0032328) |
0.3 | 0.6 | GO:0032364 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.3 | 6.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.3 | 2.5 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.3 | 0.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 0.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 7.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 0.3 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.3 | 0.6 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.3 | 0.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.3 | 2.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 0.8 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.3 | 0.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 9.4 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.3 | 2.5 | GO:0032095 | regulation of response to food(GO:0032095) |
0.3 | 0.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 1.9 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 0.3 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.3 | 0.8 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.3 | 0.5 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 3.8 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.3 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 0.5 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.3 | 0.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.8 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.3 | 2.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 0.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.3 | 4.5 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.3 | 1.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 1.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 0.3 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.3 | 3.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.3 | 0.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 0.8 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.3 | 0.8 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.5 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.3 | 0.8 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 0.8 | GO:0015816 | glycine transport(GO:0015816) |
0.3 | 5.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.3 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 0.5 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.8 | GO:0014075 | response to amphetamine(GO:0001975) response to amine(GO:0014075) |
0.3 | 0.5 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 1.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 1.0 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 1.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 0.2 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.2 | 3.2 | GO:0051904 | pigment granule transport(GO:0051904) |
0.2 | 0.7 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 1.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.2 | 0.2 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.2 | 7.5 | GO:0021549 | cerebellum development(GO:0021549) |
0.2 | 1.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.5 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 1.9 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.5 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 2.1 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.2 | 3.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 0.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 0.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 0.7 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.2 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.7 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.2 | 1.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 1.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.7 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.2 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 1.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.2 | GO:0045357 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) |
0.2 | 0.9 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 0.2 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.2 | 1.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 1.6 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.2 | 0.7 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 1.6 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.2 | 0.4 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.2 | 0.7 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 13.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 1.3 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 2.6 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 1.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.4 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 0.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 1.9 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 0.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.6 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.2 | 0.2 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 0.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.2 | 0.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.2 | 22.9 | GO:0007409 | axonogenesis(GO:0007409) |
0.2 | 0.6 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.2 | 0.2 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.2 | 0.4 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.2 | 0.6 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.6 | GO:0051195 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.2 | 1.0 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.4 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.4 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.2 | 0.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 1.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 1.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 3.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.2 | 0.2 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.2 | 0.4 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 12.8 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
0.2 | 0.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.2 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.2 | 0.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 1.9 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.2 | 1.7 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.2 | 0.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 0.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.2 | GO:0060440 | trachea formation(GO:0060440) |
0.2 | 0.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 1.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 3.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 4.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 1.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.5 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 0.2 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 0.9 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 4.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.2 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 0.2 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 1.4 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.2 | 0.9 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 1.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.3 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.2 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 0.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.2 | 1.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 0.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.2 | 0.7 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.2 | 0.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 0.7 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.2 | 0.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.7 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 | 1.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.3 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.2 | 0.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 0.2 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.2 | 0.6 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.2 | 0.2 | GO:0048382 | mesendoderm development(GO:0048382) |
0.2 | 3.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 0.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.2 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.2 | 2.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.7 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.3 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.1 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.7 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 2.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 1.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.9 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.4 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 1.0 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 1.0 | GO:0032094 | response to food(GO:0032094) |
0.1 | 1.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.4 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.8 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.8 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 1.1 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 1.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.5 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.1 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) regulation of eosinophil degranulation(GO:0043309) |
0.1 | 0.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.4 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 1.4 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.7 | GO:0070922 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) small RNA loading onto RISC(GO:0070922) |
0.1 | 0.7 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.8 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.3 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.3 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.2 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 0.2 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.4 | GO:0048570 | notochord formation(GO:0014028) notochord morphogenesis(GO:0048570) |
0.1 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.6 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 3.3 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.5 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.1 | 3.3 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.1 | 0.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.1 | 0.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.5 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.6 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 1.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.3 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 0.1 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.1 | 0.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 1.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.2 | GO:0090330 | regulation of platelet aggregation(GO:0090330) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.3 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.1 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.1 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:1903750 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.3 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 2.5 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 1.2 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.1 | 0.3 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 1.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.1 | 1.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.2 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.1 | 0.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.1 | 0.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.4 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 2.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.2 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.1 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
0.1 | 0.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.5 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.2 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.3 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.4 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 1.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 3.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.1 | 0.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.5 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.1 | 0.3 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.2 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.2 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.2 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 1.0 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.3 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.3 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.9 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 1.6 | GO:0016358 | dendrite development(GO:0016358) |
0.1 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.2 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.3 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 1.6 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.1 | 0.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 1.5 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.4 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.2 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.3 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) oligopeptide transmembrane transport(GO:0035672) tripeptide transport(GO:0042939) |
0.1 | 0.2 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.5 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.3 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.1 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.2 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.4 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.2 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 1.0 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.4 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.1 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 1.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 1.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.1 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.1 | 0.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.4 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.2 | GO:0052405 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.1 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.1 | 0.7 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 2.5 | GO:0010975 | regulation of neuron projection development(GO:0010975) |
0.1 | 0.1 | GO:1900094 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.1 | 0.4 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.3 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.1 | 1.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.5 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.0 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.0 | 1.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 1.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.3 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 1.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0072679 | B cell chemotaxis(GO:0035754) thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.0 | 0.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0050433 | regulation of catecholamine secretion(GO:0050433) |
0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.0 | GO:0003129 | heart induction(GO:0003129) |
0.0 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.0 | GO:1902744 | actin filament branching(GO:0090135) negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.2 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
0.0 | 0.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.0 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.0 | 0.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.0 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.0 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.4 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 0.1 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.1 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.1 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.0 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.0 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.0 | 0.5 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.0 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.0 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.0 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.0 | 0.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.0 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.0 | 0.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.0 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
0.0 | 0.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.7 | 21.4 | GO:0043083 | synaptic cleft(GO:0043083) |
2.3 | 6.9 | GO:0072534 | perineuronal net(GO:0072534) |
2.3 | 22.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.9 | 5.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.9 | 17.3 | GO:0005883 | neurofilament(GO:0005883) |
1.9 | 1.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.8 | 12.3 | GO:0032584 | growth cone membrane(GO:0032584) |
1.7 | 13.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.7 | 31.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.6 | 9.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.6 | 8.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.6 | 14.2 | GO:0030673 | axolemma(GO:0030673) |
1.5 | 7.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.4 | 71.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.4 | 5.6 | GO:0044308 | axonal spine(GO:0044308) |
1.3 | 8.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.2 | 14.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.1 | 26.4 | GO:0044295 | axonal growth cone(GO:0044295) |
1.1 | 3.2 | GO:0097441 | basilar dendrite(GO:0097441) |
1.0 | 2.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.0 | 13.5 | GO:0031045 | dense core granule(GO:0031045) |
1.0 | 7.2 | GO:0043194 | axon initial segment(GO:0043194) |
1.0 | 1.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.0 | 24.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.0 | 165.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.0 | 10.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.0 | 4.9 | GO:0097433 | dense body(GO:0097433) |
1.0 | 5.8 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.9 | 27.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.9 | 8.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.9 | 11.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.9 | 8.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.8 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.8 | 2.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.8 | 6.8 | GO:0097449 | astrocyte projection(GO:0097449) |
0.7 | 1.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.7 | 2.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.7 | 4.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 36.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.7 | 0.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.7 | 2.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.6 | 4.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 7.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.6 | 3.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 1.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 17.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.6 | 2.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.6 | 13.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.6 | 8.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.6 | 49.0 | GO:0030426 | growth cone(GO:0030426) |
0.5 | 2.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.5 | 0.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.5 | 5.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.5 | 1.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.5 | 1.5 | GO:0031417 | NatC complex(GO:0031417) |
0.5 | 1.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 7.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.5 | 1.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 3.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 37.4 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 2.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.5 | 3.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 10.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.4 | 1.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 1.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.4 | 0.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.4 | 2.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 1.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.4 | 2.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.4 | 12.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 22.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 2.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 4.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.4 | 1.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 4.9 | GO:0043205 | fibril(GO:0043205) |
0.3 | 5.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 27.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.3 | 0.7 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.3 | 2.7 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 1.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.3 | 2.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 0.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 44.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 2.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.3 | 0.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 0.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 1.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 1.4 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 1.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 0.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 5.6 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.3 | 1.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 2.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 1.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 1.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 1.6 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 2.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 1.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 2.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 2.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 1.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 0.8 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 1.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 1.2 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 3.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.7 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 3.0 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 3.3 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 1.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 0.7 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 1.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 51.3 | GO:0045202 | synapse(GO:0045202) |
0.2 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 0.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 3.9 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 1.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 2.8 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 0.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 1.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 3.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 8.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 0.7 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 2.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 21.9 | GO:0030425 | dendrite(GO:0030425) |
0.2 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 1.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 2.0 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.2 | 0.8 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 3.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.8 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 1.2 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 3.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.7 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.9 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 1.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 1.1 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 1.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 1.9 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.5 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.5 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 0.3 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 3.2 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 2.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.9 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 3.3 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 1.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 1.7 | GO:0044297 | cell body(GO:0044297) |
0.1 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 3.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 21.2 | GO:0097458 | neuron part(GO:0097458) |
0.1 | 2.0 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 1.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 2.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 1.2 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.6 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.1 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0036396 | MIS complex(GO:0036396) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 19.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
4.7 | 9.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
4.5 | 13.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.5 | 10.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.2 | 12.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
3.1 | 24.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
2.8 | 25.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.8 | 14.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.5 | 7.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.2 | 15.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.1 | 12.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.1 | 10.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.9 | 11.4 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.9 | 16.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.8 | 5.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.8 | 5.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.7 | 3.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.6 | 17.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.6 | 4.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.6 | 7.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.5 | 7.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.5 | 10.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.4 | 17.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.2 | 3.7 | GO:0035939 | microsatellite binding(GO:0035939) |
1.2 | 2.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.2 | 3.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.2 | 4.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.1 | 12.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.1 | 2.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.1 | 5.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.1 | 11.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.1 | 2.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.1 | 1.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.1 | 2.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.1 | 7.4 | GO:0003680 | AT DNA binding(GO:0003680) |
1.1 | 4.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.0 | 3.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.0 | 4.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.0 | 3.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.0 | 19.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.0 | 4.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.0 | 7.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.0 | 3.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.0 | 19.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.9 | 7.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.9 | 2.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.9 | 4.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.9 | 2.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.8 | 9.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.8 | 8.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.8 | 4.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.8 | 2.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.8 | 4.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.8 | 15.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.8 | 4.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.8 | 2.4 | GO:0070538 | oleic acid binding(GO:0070538) |
0.8 | 4.9 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.8 | 5.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.8 | 1.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.8 | 3.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 19.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.8 | 0.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.8 | 3.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.8 | 2.3 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.7 | 2.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.7 | 5.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.7 | 2.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 1.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.7 | 2.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.7 | 0.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.7 | 3.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.7 | 2.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.7 | 9.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.7 | 2.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.7 | 13.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.7 | 7.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.6 | 1.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.6 | 4.5 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 3.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.6 | 10.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.6 | 1.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.6 | 1.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.6 | 8.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.6 | 6.7 | GO:0005522 | profilin binding(GO:0005522) |
0.6 | 0.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.6 | 2.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.6 | 1.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.6 | 1.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 1.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.6 | 0.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.6 | 1.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.6 | 1.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.6 | 18.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.6 | 2.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 1.7 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.6 | 2.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.6 | 1.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.6 | 1.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.5 | 9.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 1.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.5 | 11.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.5 | 5.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.5 | 1.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 2.6 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.5 | 2.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.5 | 2.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.5 | 5.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.5 | 1.6 | GO:0043918 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.5 | 6.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.5 | 14.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 11.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.5 | 3.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.5 | 7.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 9.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.5 | 4.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 4.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.5 | 1.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 3.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.5 | 8.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.5 | 2.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 3.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 2.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 1.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.5 | 2.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 1.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 11.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.5 | 0.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 2.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 1.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.4 | 1.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.4 | 0.4 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.4 | 5.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 1.3 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.4 | 8.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 1.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 10.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 1.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 8.6 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.4 | 7.8 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 32.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.4 | 0.4 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.4 | 4.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 1.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 0.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 1.7 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.4 | 2.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 1.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.4 | 4.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 1.6 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 3.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.4 | 3.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.4 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 1.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 0.4 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.4 | 1.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 7.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 1.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.4 | 1.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.4 | 0.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.4 | 1.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 1.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 0.7 | GO:0034810 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.4 | 1.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.4 | 0.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.3 | 3.1 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 2.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 0.7 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 1.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 1.0 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 2.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 2.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 1.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 1.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 5.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 0.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 4.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 0.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 0.9 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.3 | 1.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 28.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 3.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 0.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 3.0 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.3 | 5.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 2.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 7.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 1.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 6.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 1.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 6.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 1.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 3.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 0.8 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 1.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 1.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 1.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 0.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 0.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 1.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.3 | 1.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 7.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 1.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 1.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 2.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 0.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 3.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 1.0 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.2 | 0.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 2.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 1.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 4.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 2.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 1.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 1.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 1.3 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 5.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.2 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.2 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 2.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 1.9 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 7.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 1.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 5.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 6.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 1.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 1.3 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.2 | 0.6 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 2.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 1.0 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.2 | 1.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 0.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 1.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 0.6 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 0.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 1.0 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 0.8 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 1.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 3.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 4.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 2.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 3.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 2.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 6.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 0.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 1.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 1.1 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 1.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 1.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 0.3 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.2 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 0.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 1.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.2 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 0.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 0.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 0.5 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 2.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 1.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.9 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 2.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.7 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 1.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 2.4 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 1.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 1.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.8 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 2.7 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 2.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 2.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 2.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 1.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 1.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 10.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.3 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 0.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 15.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 2.5 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.1 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 2.1 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 1.4 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 1.2 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 1.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.6 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.3 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 1.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 1.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 11.4 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.9 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 2.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 2.3 | GO:0005261 | cation channel activity(GO:0005261) |
0.1 | 0.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 2.0 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 2.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.4 | GO:0005165 | neurotrophin receptor binding(GO:0005165) neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 29.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 14.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 0.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 0.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 3.4 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 1.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.7 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.2 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.0 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.0 | 0.2 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.8 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.3 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.4 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 1.9 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 1.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.0 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.9 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.6 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.5 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.0 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 16.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.6 | 9.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 0.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 15.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 12.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.5 | 10.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 5.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 0.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 30.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.4 | 12.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 6.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 5.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 17.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 8.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 7.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 12.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 5.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 5.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 8.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 5.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 1.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 9.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 4.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 3.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 1.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 1.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 3.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 6.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 3.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 3.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 3.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 3.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 3.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 4.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 4.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 0.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 2.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 6.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 1.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 2.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 2.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 7.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 6.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 4.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | ST STAT3 PATHWAY | STAT3 Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 21.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.7 | 39.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.5 | 31.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.4 | 20.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.4 | 23.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.3 | 10.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.3 | 17.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.1 | 8.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.1 | 12.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.1 | 1.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.0 | 6.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.9 | 10.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.9 | 21.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.8 | 3.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.8 | 5.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.8 | 33.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.8 | 3.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.7 | 10.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 2.6 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.6 | 11.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 10.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 4.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 3.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 11.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.5 | 9.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.5 | 4.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.5 | 20.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.5 | 0.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.5 | 9.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 6.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 0.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 1.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 3.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.4 | 1.6 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.4 | 1.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 9.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 2.8 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.4 | 1.2 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.4 | 2.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.4 | 6.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 0.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.4 | 4.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 10.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 1.0 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.3 | 7.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 3.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 3.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 0.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 5.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 4.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 3.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 4.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 1.4 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.3 | 10.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.3 | 2.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 0.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.3 | 0.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 3.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 3.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 2.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 1.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 3.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 4.1 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 3.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 2.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 1.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 4.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 1.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.2 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 2.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 3.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 1.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 2.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 24.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 2.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 1.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 2.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 3.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 3.8 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 1.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 5.6 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 5.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 2.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 3.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.0 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 1.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.7 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |